First-line zongertinib showed antitumor activity in treatment-naive patients with advanced or metastatic HER2-mutant ...

Chemotherapy has been the standard for previously untreated advanced or metastatic HER2-mutant lung cancer. In this phase I ...

In a preclinical study published in Cancer Research, researchers from the University of Texas MD Anderson Cancer Center have ...

A new research perspective was published in Volume 13 of Oncoscience on March 11, 2026, titled "Early success of the COCOON trial: Preventing dermatologic adverse events in first-line EGFR-mutant ...

Barry Manilow is now cancer-free after undergoing a successful surgery to remove part of his lung. “I’m one of the lucky ones,” the singer told People in a new interview, adding, “This really rocked ...

Lung cancer causes abnormal cells to grow in your lungs. You are at higher risk for lung cancer if you are a current smoker or have smoked regularly in the past. But anyone can get lung cancer. In ...

A severe case of COVID-19 or influenza could increase the risk of lung cancer later on, according to new research. Scientists discovered that serious viral infections can alter immune cells in the ...

Vanessa Etienne is a Staff Writer for PEOPLE on the Health team. She joined the brand in 2021. 7NEWS Australia/YouTube Mel McLaughlin revealed her stage 2 lung cancer diagnosis after a recent absence ...

New research from UVA Health finds severe COVID-19 and influenza can prime the lungs for cancer and speed the disease’s development, but vaccination can help prevent those effects. “A bad case of ...

Lung adenocarcinoma is the most common type of lung cancer diagnosed in the U.S. Just over half of all non-small-cell lung cancers (NSCLCs) are adenocarcinomas. Finding out that you're at risk of lung ...

A phase 3 global trial is enrolling previously treated locally advanced/metastatic nonsquamous NSCLC to define DATROWAY efficacy and safety at scale. IDE034 is in open-label phase 1 ...

Stage 4 lung cancer used to be a death sentence. Today the survival rate has been steadily on the rise since the 1990s. Now a new targeted treatment that's helping extend the lives of some lung cancer ...